Skip to content

A clinical study on the treatment of acute respiratory distress syndrome patients with Bawei Dingchuan Decoction based on the theory of 'compensating the insufficient with the excess'.

A clinical study on the treatment of acute respiratory distress syndrome patients with Bawei Dingchuan Decoction based on the theory of 'compensating the insufficient with the excess'.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2026000625
Enrollment
Unknown
Registered
2026-03-19
Start date
2025-12-20
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute Respiratory Distress Syndrome

Interventions

control group:The control group received standard treatment. All patients were given comprehensive Western medicine treatment and special ICU care after admission, including treatment for the primary
intervention group:The experimental group was given additional Bawei Dingchuan Decoction (composed of: 15g of mulberry root bark, 15g of scutellaria baicalensis, 12g of rhubarb, 15g of trichosanthes p

Sponsors

Chongqing Traditional Chinese Medicine Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1.Meets the diagnostic criteria for ARDS according to Western medicine and Traditional Chinese Medicine; 2.Requires invasive mechanical ventilation treatment for more than 3 days; 3. Age between 18 and 90 years; 4. The patient or family member is willing to sign an informed consent form and participate in the study.

Exclusion criteria

Exclusion criteria: 1.Severe obesity BMI > 40 Kg/m²; 2.Severe primary diseases and other terminal diseases that affect survival, including: uncontrolled malignant tumors that are metastasized to multiple locations and cannot be removed, blood diseases, and HIV, etc.; 3.Expected survival time of less than 48 hours; 4.Patients with neuromuscular diseases;5. Known allergy to the components of Bawei Dingchuan Decoction or those with allergic constitutions; 6.Pregnant and postpartum women;7.Patients who are uncooperative, or refuse active treatment.

Design outcomes

Primary

MeasureTime frame
The Duration of Invasive Mechanical Ventilation;28-day Mortality Rate;

Secondary

MeasureTime frame
Vital Signs(temperature, heart rate, blood pressure, etc.);Breathing Condition(respiratory rate, etc.);Organ Function(liver function, kidney function, etc.);Inflammation Marker(white blood cells, procalcitonin, etc.);Immune Indicators(lymphocyte count, etc.);

Countries

China

Contacts

Public ContactRen Dongsheng

Chongqing Traditional Chinese Medicine Hospital

2250193681@qq.com+86 185 8255 9895

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Apr 4, 2026